Specialty Pharmacy

May 25, 2016

New HCV Treatments: High Short-Term Costs, Long-Term Savings

May 17, 2016

Hepatitis C: Pharmacists’ Contribution to Optimizing Disease Management

Hepatitis C virus (HCV) affects more than 3% of the global population, and approximately 160 million people have chronic HCV.

May 17, 2016

Specialty Pharmacy: What’s the Impact on Community Practice?

Community pharmacists were surveyed to determine their awareness of the specialty market.

February 17, 2016

Specialty Medications in the Management of Rheumatoid Arthritis

Rheumatoid arthritis is a chronic, inflammatory, systemic autoimmune disorder characterized by symmetrical, erosive synovitis frequently leading to joint destruction, deformity, and disability.

January 20, 2016

Current Perspectives on Multiple Sclerosis

MS manifests as neurologic signs and symptoms related to declining neuromuscular, sensory, and cognitive function, with a waxing and waning pattern of symptoms and/or continuous disease progression.

January 20, 2016

Muscular Dystrophy: Options for Complication Management

There are nine clearly defined types of muscular dystrophy, each differing in age of onset, clinical symptomology, muscle groups impacted, and associated complications.

January 20, 2016

Getting the Word Out

As the specialty pharmacy market grows, so too should the effort to communicate potential interactions.

December 14, 2015

Ulcerative Colitis

This type of inflammatory bowel disease causes swelling and ulceration of the inner lining of the large intestine and rectum.

October 16, 2015

Preventive HIV Vaccines: Progress and Challenges

Despite the success of standard regimens, antiretroviral therapy is complicated by potential drug-drug interactions, patient nonadherence, and adverse effects.

October 16, 2015